Women (Breast) Checkup

US$841
NT$27,000 · you pay the hospital in NT$
Book this checkup

Prefer to book it yourself? Call Chi Mei Medical Center on 06-2812811 (ext. 53541~53545) or use its website ↗. It's free; most hospitals take bookings in Chinese.

We book it with the hospital for you, from US$149, paid only after the hospital confirms. We reply by email with available dates, the confirmed price, and whether an English report is available.

Paying from a US account? HSA and FSA notes.

Share on LINE / 分享到 LINE

As published by the hospital · checked 2026-09-20

A specialty-tier program with Breast MRI, Breast ultrasound and Pelvic (gynecologic) ultrasound and a 47-test panel, with a doctor's review at the end.

Takes
1 day
Fasting
8 hours before
Bowel prep
Not required
Deposit
US$156 (NT$5,000)
English report
Ask the hospital (we ask for you in Book it for me)

What stands out

Breast MRI

Breast cancer in high-risk women.

Breast ultrasound

Breast lumps; complements mammography, especially in dense breasts.

Pelvic (gynecologic) ultrasound

Uterus and ovary abnormalities (fibroids, cysts).

Every test, in English

47 tests listed, 36 of them on our shared test list, so they line up against other hospitals' packages.

Vitals5
Blood Count3
Liver Function1
Kidney & Electrolytes3
Lipids & Cardiometabolic5
Glucose2
Thyroid & Endocrine5
Tumor Markers1
Urine & Stool2
X-ray1
Ultrasound2
MRI Imaging1
Women's Health1
Eye2
ENT & Dental1
Consultation1
Show all 47 tests and what each screens for
TestScreens for
Vitals
Blood pressureScreens for hypertension, a major risk factor for heart disease and stroke.
Body composition analysisBody fat, muscle mass and water percentage.
Height, weight and BMIBasic body measurements used to assess weight-related health risk.
Basic vital signs (pulse, temperature, respiration)Basic pulse, temperature and breathing rate measurements taken during a checkup.
Waist circumferenceCentral obesity, a marker of metabolic risk.
Blood Count
Complete blood countAnemia, infection and blood cell disorders.
Vitamin B12 and folateDeficiencies that cause anemia and nerve problems.
White blood cell differentialBreakdown of white cell types; infection, allergy and some blood cancers.
Liver Function
Total bilirubinJaundice, liver and bile problems.
Kidney & Electrolytes
Blood urea nitrogenKidney function.
CreatinineKidney function.
Uric acidGout risk and kidney stone risk.
Lipids & Cardiometabolic
HDL cholesterolProtective cholesterol level.
LDL cholesterolThe main cholesterol driving heart disease risk.
Lipoprotein(a)Inherited cardiovascular risk not captured by LDL.
Total cholesterolCardiovascular risk.
TriglyceridesCardiovascular and pancreatitis risk.
Glucose
Fasting glucoseDiabetes and prediabetes.
Hemoglobin A1cAverage blood sugar over the past three months; diabetes.
Thyroid & Endocrine
AMH (ovarian reserve)Ovarian reserve / fertility potential.
Free T4Thyroid hormone level.
T3Thyroid hormone level.
TSHThyroid function; the primary thyroid screening test.
Vitamin D (25-OH)Vitamin D deficiency; bone health.
Tumor Markers
CA-125Ovarian cancer marker.
Urine & Stool
UrinalysisKidney disease, urinary infection, diabetes.
Urine microalbumin / ACREarly kidney damage, especially in diabetes and hypertension.
X-ray
Chest X-rayLung, heart size and chest abnormalities.
Ultrasound
Breast ultrasoundBreast lumps; complements mammography, especially in dense breasts.
Pelvic (gynecologic) ultrasoundUterus and ovary abnormalities (fibroids, cysts).
MRI Imaging
Breast MRIBreast cancer in high-risk women.
Women's Health
MammographyBreast cancer; the standard screen for women 40+.
Eye
Color visionColor vision deficiency.
Visual acuityVision sharpness.
ENT & Dental
Hearing testHearing loss.
Consultation
Physician physical examinationA doctor's hands-on examination and history taking.
Vitals
Blood pressure
Screens for hypertension, a major risk factor for heart disease and stroke.
Body composition analysis
Body fat, muscle mass and water percentage.
Height, weight and BMI
Basic body measurements used to assess weight-related health risk.
Basic vital signs (pulse, temperature, respiration)
Basic pulse, temperature and breathing rate measurements taken during a checkup.
Waist circumference
Central obesity, a marker of metabolic risk.
Blood Count
Complete blood count
Anemia, infection and blood cell disorders.
Vitamin B12 and folate
Deficiencies that cause anemia and nerve problems.
White blood cell differential
Breakdown of white cell types; infection, allergy and some blood cancers.
Liver Function
Total bilirubin
Jaundice, liver and bile problems.
Kidney & Electrolytes
Blood urea nitrogen
Kidney function.
Creatinine
Kidney function.
Uric acid
Gout risk and kidney stone risk.
Lipids & Cardiometabolic
HDL cholesterol
Protective cholesterol level.
LDL cholesterol
The main cholesterol driving heart disease risk.
Lipoprotein(a)
Inherited cardiovascular risk not captured by LDL.
Total cholesterol
Cardiovascular risk.
Triglycerides
Cardiovascular and pancreatitis risk.
Glucose
Fasting glucose
Diabetes and prediabetes.
Hemoglobin A1c
Average blood sugar over the past three months; diabetes.
Thyroid & Endocrine
AMH (ovarian reserve)
Ovarian reserve / fertility potential.
Free T4
Thyroid hormone level.
T3
Thyroid hormone level.
TSH
Thyroid function; the primary thyroid screening test.
Vitamin D (25-OH)
Vitamin D deficiency; bone health.
Tumor Markers
CA-125
Ovarian cancer marker.
Urine & Stool
Urinalysis
Kidney disease, urinary infection, diabetes.
Urine microalbumin / ACR
Early kidney damage, especially in diabetes and hypertension.
X-ray
Chest X-ray
Lung, heart size and chest abnormalities.
Ultrasound
Breast ultrasound
Breast lumps; complements mammography, especially in dense breasts.
Pelvic (gynecologic) ultrasound
Uterus and ovary abnormalities (fibroids, cysts).
MRI Imaging
Breast MRI
Breast cancer in high-risk women.
Women's Health
Mammography
Breast cancer; the standard screen for women 40+.
Eye
Color vision
Color vision deficiency.
Visual acuity
Vision sharpness.
ENT & Dental
Hearing test
Hearing loss.
Consultation
Physician physical examination
A doctor's hands-on examination and history taking.
Also listed: Liquid-based Pap smear, Nurse-led follow-up reminder and tracking based on checkup results, Red blood cell count, Selenium, Urine appearance, Urine color, Urine protein, Urine sediment (RBC, WBC, epithelial cells), Vitamin C, White blood cell count, Zinc.

Before you book

Fasting8 hours before
Bowel prepNot required
DepositUS$156 (NT$5,000)
SexFor women
If something is foundAsk the hospital how any findings are explained, on the day or at a follow-up appointment; in Book it for me we ask for you and tell you before you book. Your own doctor decides what to do next; we do not arrange treatment.
Results and imagingAsk the hospital how long results take and how imaging is delivered; in Book it for me we ask for you and tell you before you book.
Chi Mei Medical Center Health Management Center
Medical center
Tainan · Yongkang

About 4 minutes' walk (277 m) from Daqiao station

On the OCAC i僑卡 partner list. Card holders can ask the center about a discount.

11 packages listed

About this hospital

What the center says

From the center's own pages, in English. Each statement links to its source.

Booking and payment
  • The center requires a NT$5,000 booking deposit for a health check-up, or NT$10,000 for the PET program.

    Source ↗ · checked 2026-09-20

  • The center accepts payment of the booking deposit by bank transfer.

    Source ↗ · checked 2026-09-20

  • The center allows cancellation or rescheduling by phone at least 6 days before the exam; a cancellation refund is issued against the original receipt minus a NT$1,000 processing fee.

    Source ↗ · checked 2026-09-20

Before and on the day
  • For the Women's Health Package, the exam date must be scheduled around the patient's menstrual cycle.

    Source ↗ · checked 2026-09-20

Add to this package

Tests this center prices separately that this package does not include.

TestPriceNote
Echocardiogramas listed: Echocardiography
US$100
NT$3,200
Low-dose chest CTas listed: Low-dose lung CT scan
US$187
NT$6,000
Abdomen and pelvis CTas listed: Abdomen CT scan (with contrast)
US$249
NT$8,000
Coronary CT angiographyas listed: CT coronary angiography
US$685
NT$22,000
Gastroscopy (upper GI endoscopy)as listed: Gastroscopy with intravenous sedation
US$220
NT$7,050
Sedated
Colonoscopyas listed: Colonoscopy with intravenous sedation, including low-fiber diet
US$266
NT$8,550
Sedated

Source ↗ · checked 2026-09-20

US price context

Bought one by one at US cash-pay marketplaces, the 35 of 36 tests we could price list at about US$2,821–3,459 (MDsave, Quest and others; checked 2026-10-11).

How we priced it

A panel counts once however many of its tests the package lists. A test for one sex only is counted only for that sex. Tests we could not price are left out, so this is not what a US checkup would cost. Prices marked "rough" come from a single reseller or are extrapolated from a similar test.

Radiation from this package's imaging

About 0.4 mSv from the tests we could identify, a typical adult dose for these exams: roughly 1 month of natural background radiation (about 3 mSv a year, US average).

This package also lists 11 items we have not matched to a test; if any of them is an X-ray, CT or PET scan, the total is higher.

  • Chest X-ray · about 0.1 mSv
  • Mammography · about 0.28 mSv

Typical doses from published references (RadiologyInfo.org ↗, Mettler et al. 2008 ↗); the actual dose depends on the scanner and protocol. Ask the center for its own figure.

What US screening guidelines say

The US Preventive Services Task Force is an independent US panel whose recommendations cover people without symptoms. Shown for comparison; it is not advice for you.

What US screening guidelines say about 17 of these tests
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for hearing loss in adults 50 years or older. (2021) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for hypertension in adults 18 years or older with office blood pressure measurement, confirmed with measurement outside the clinical setting before starting treatment. (2021) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of supplemental screening with breast ultrasound in women found to have dense breasts on an otherwise negative screening mammogram. (2024) · USPSTF ↗ Note: Same I statement covers ultrasound and MRI as supplemental tests; see mri_breast. The USPSTF breast cancer screening statement does not apply to people at high risk of breast cancer (for example BRCA1/2 carriers or others with a high-risk genetic marker or syndrome, people who had high-dose chest radiation at a young age, or people with previous breast cancer or a high-risk breast lesion).
Recommended against (grade D)The USPSTF recommends against screening for ovarian cancer in asymptomatic women, including with the CA-125 blood test. (2018) · USPSTF ↗ Note: Same D-grade recommendation covers CA-125 and transvaginal/pelvic ultrasound; see pelvic_ultrasound.
Recommended (grade A/B)The USPSTF recommends screening for prediabetes and type 2 diabetes, including with a fasting plasma glucose test, in adults aged 35 to 70 years who have overweight or obesity. (2021) · USPSTF ↗ Note: Same recommendation names fasting plasma glucose, HbA1c and the oral glucose tolerance test as acceptable screening tests. The USPSTF suggests clinicians consider screening at an earlier age in groups with higher diabetes prevalence, including Asian American persons, and at a lower BMI (23 or higher) in Asian American persons.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults. (2015) · USPSTF ↗ Note: The I statement concerns screening for thyroid dysfunction, for which the USPSTF names serum TSH as the primary screening test; T4 is described as follow-up testing after a persistently abnormal TSH.
Recommended (grade A/B)The USPSTF recommends screening for prediabetes and type 2 diabetes, including with a hemoglobin A1c test, in adults aged 35 to 70 years who have overweight or obesity. (2021) · USPSTF ↗ Note: Same recommendation names fasting plasma glucose, HbA1c and the oral glucose tolerance test as acceptable screening tests. The USPSTF suggests clinicians consider screening at an earlier age in groups with higher diabetes prevalence, including Asian American persons, and at a lower BMI (23 or higher) in Asian American persons.
Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Recommended (grade A/B)The USPSTF recommends that clinicians offer or refer adults with a body mass index of 30 or higher to intensive, multicomponent behavioral weight-loss interventions. (2018; an update is in progress) · USPSTF ↗ Note: The grade applies to offering or referring adults with a BMI of 30 or higher to intensive behavioral weight-loss programs, not to measuring height, weight or BMI; the USPSTF says screening for obesity is now part of routine clinical practice and was not a focus of its review. The USPSTF lists an update in progress, folded into a combined topic on healthy diet, physical activity and weight loss to prevent cardiovascular disease; the 2018 statement remains the current final recommendation as of 2026-09-25.
Recommended (grade A/B)The USPSTF recommends biennial screening mammography for women aged 40 to 74 years. (2024) · USPSTF ↗ Note: The USPSTF breast cancer screening statement does not apply to people at high risk of breast cancer (for example BRCA1/2 carriers or others with a high-risk genetic marker or syndrome, people who had high-dose chest radiation at a young age, or people with previous breast cancer or a high-risk breast lesion).
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening mammography in women 75 years or older. (2024) · USPSTF ↗ Note: The USPSTF breast cancer screening statement does not apply to people at high risk of breast cancer (for example BRCA1/2 carriers or others with a high-risk genetic marker or syndrome, people who had high-dose chest radiation at a young age, or people with previous breast cancer or a high-risk breast lesion).
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of supplemental screening with breast MRI in women found to have dense breasts on an otherwise negative screening mammogram. (2024) · USPSTF ↗ Note: Same I statement covers MRI and ultrasound as supplemental tests; see breast_ultrasound. The USPSTF breast cancer screening statement does not apply to people at high risk of breast cancer (for example BRCA1/2 carriers or others with a high-risk genetic marker or syndrome, people who had high-dose chest radiation at a young age, or people with previous breast cancer or a high-risk breast lesion) and does not address MRI screening for those groups.
Recommended against (grade D)The USPSTF recommends against screening for ovarian cancer in asymptomatic women, including with transvaginal ultrasound. (2018) · USPSTF ↗ Note: Same D-grade recommendation covers pelvic/transvaginal ultrasound and the CA-125 blood test; see ca125. This csv does not map pelvic_ultrasound to any recommendation about non-ovarian pelvic findings (fibroids, cysts), which the USPSTF does not address.
Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults. (2015) · USPSTF ↗ Note: The I statement concerns screening for thyroid dysfunction, for which the USPSTF names serum TSH as the primary screening test; T4 is described as follow-up testing after a persistently abnormal TSH.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for bladder cancer in asymptomatic adults. (2011) · USPSTF ↗ Note: The USPSTF lists urine dipstick or microscopic urinalysis for hematuria (blood in the urine) among the bladder cancer screening tests it considered. This note covers only that use of a urinalysis.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for impaired visual acuity in older adults. (2022) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for vitamin D deficiency in asymptomatic adults. (2021) · USPSTF ↗
General preparation notes for 10 tests in this package

This is general information about how the exam is usually done, not medical advice for you or your family member. Requirements vary by center and by individual health history — always follow the center's own instructions and your own doctor's guidance, especially for any medicine change.

Body composition analysis

Mention when booking: Mention a pacemaker or implanted defibrillator: the test passes a weak electric current through the body and has traditionally not been recommended with these devices.

Total cholesterol

Fasting for 9 to 12 hours (no food or drink except plain water) is often requested, so the test is often done in the morning.

Mention when booking: Confirm with the center whether your test needs fasting; if you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting.

Triglycerides

Fasting for 9 to 12 hours (no food or drink except plain water) is often requested.

Mention when booking: Confirm with the center whether your test needs fasting; if you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting.

Fasting glucose

Usually needs at least 8 hours without food or drink except water beforehand.

Mention when booking: If you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting, and mention it to the center.

Urinalysis

Usually needs a clean-catch (midstream) sample; some tests instead ask you to collect all urine passed over 24 hours.

Mention when booking: Ask which specific urine test your provider ordered, since collection instructions vary by test.

Chest X-ray

Usually needs no fasting; you remove jewelry, metal objects and sometimes clothing above the waist for a hospital gown.

Mention when booking: Tell the center if you are, or might be, pregnant.

Pelvic (gynecologic) ultrasound

For a transabdominal scan, drinking water beforehand to fill the bladder is common; for a transvaginal scan, an empty bladder is usual instead.

Mention when booking: Tell the center which type of scan you expect, and mention if you are, or might be, pregnant.

Breast MRI

Guidelines on eating and drinking vary by center. Contrast is usually injected through an IV. Leave jewelry at home and wear loose, comfortable clothing.

Mention when booking: Mention breast implants, a pacemaker or other implanted device, metal fragments, pregnancy, kidney disease or dialysis, a contrast allergy, or claustrophobia.

Afterwards: If you take a sedative for claustrophobia or anxiety, you'll need someone to take you home; arrange this before the scan.

Mammography

Usually asks that you skip deodorant, powder or lotion on the underarms and breasts, since these can look like calcium spots on the image. Bring prior mammograms from elsewhere if you have them.

Mention when booking: Mention breast implants, any breast symptoms, prior breast surgery, hormone use, or the possibility of pregnancy.

Afterwards: You may be asked to wait until the radiologist confirms the images are complete; ask when to expect results.

Hearing test

Usually needs no special preparation; expect to listen for tones or words through headphones, and sometimes a small probe checks how the eardrum moves.

Sources
As published by the hospital · checked 2026-09-20

How we collect and check these prices: see who we are and where the data comes from.

US$ at 32.1 TWD, 23 Sep 2026; you pay in NT$.
Women (Breast) Checkup
US$841
Book this checkup

If this isn't quite right

Other packages at Chi Mei Medical Center

PackageTestsPrice
Young Checkup65
US$343
NT$11,000
Lung Checkup76
US$654
NT$21,000
Women US$779
Heart & Carotid Checkup78
US$685
NT$22,000
Women US$810
Heart Checkup22
US$779
NT$25,000
Digestive Checkup75
US$872
NT$28,000
Women US$997
Abdomen Checkup48
US$966
NT$31,000
PET Package20
US$1,308
NT$42,000
CII Checkup76
US$2,492
NT$80,000
Women US$2,617
AA Checkup78
US$2,804
NT$90,000
Women US$2,960
CII+Heart Checkup77
US$3,178
NT$102,000
Women US$3,302

All packages at Chi Mei Medical Center Health Management Center →

Similar packages in Tainan

All checkups in Tainan →

US$ at 32.1 TWD, 23 Sep 2026; you pay in NT$.

Browse: Women's health · All checkups in Tainan · What a checkup costs in Taiwan